Lake Street raised the firm’s price target on Koru Medical (KRMD) to $5 from $4 and keeps a Buy rating on the shares after the company announced preliminary Q4 revenue that beat the firm’s and Street’s estimates. While the preliminary release provided limited detail into what drove the beat, the firm suspects broad-based business strength given the size of the beat, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRMD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue